Team:Peking R/HumanPractice/CurrentSituations

From 2011.igem.org

(Difference between revisions)
 
(8 intermediate revisions not shown)
Line 3: Line 3:
{{https://2011.igem.org/Team:Peking_R/back2}}
{{https://2011.igem.org/Team:Peking_R/back2}}
{{https://2011.igem.org/Team:Peking_R/Humanpracticebackground}}
{{https://2011.igem.org/Team:Peking_R/Humanpracticebackground}}
-
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
+
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ice="http://ns.adobe.com/incontextediting">
-
<html xmlns="http://www.w3.org/1999/xhtml">
+
<head>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
Line 14: Line 13:
top:319px;
top:319px;
width:655px;
width:655px;
-
height:2123px;
+
height:1723px;
-
z-index:2;
+
z-index:1;
font-family: "Comic Sans MS", cursive;
font-family: "Comic Sans MS", cursive;
font-size: 14px;
font-size: 14px;
color: #333;
color: #333;
text-align: justify;
text-align: justify;
-
background-color: #E9FEF0;
+
background-color: #FFFFFF;
}
}
.notbookmaintitle {
.notbookmaintitle {
Line 27: Line 26:
color: #000;
color: #000;
font-weight: bold;
font-weight: bold;
-
text-align: center;
 
}
}
.name {
.name {
Line 102: Line 100:
#apDiv3 {
#apDiv3 {
position:absolute;
position:absolute;
-
left:561px;
+
left:36px;
-
top:2403px;
+
top:291px;
-
width:130px;
+
width:540px;
height:28px;
height:28px;
z-index:2;
z-index:2;
Line 129: Line 127:
#apDiv4 {
#apDiv4 {
position:absolute;
position:absolute;
-
left:77px;
+
left:61px;
-
top:527px;
+
top:388px;
-
width:599px;
+
width:610px;
-
height:1725px;
+
height:1910px;
-
z-index:3;
+
z-index:2;
text-align: justify;
text-align: justify;
color: #000;
color: #000;
-
font-family: Georgia, "Times New Roman", Times, serif;
+
font-family: "Times New Roman", Times, serif;
}
}
.mainbody {
.mainbody {
text-align: justify;
text-align: justify;
-
color: #333;
+
color: #000;
 +
font-family: Georgia, "Times New Roman", Times, serif;
 +
font-size: 16px;
}
}
.main {
.main {
-
color: #063;
+
color: #000;
font-weight: bold;
font-weight: bold;
 +
font-family: Arial, Helvetica, sans-serif;
}
}
.clickteam #apDiv4 .download .mainbody {
.clickteam #apDiv4 .download .mainbody {
Line 155: Line 156:
width:610px;
width:610px;
height:687px;
height:687px;
-
z-index:4;
+
z-index:3;
}
}
-
#apDiv6 {
+
.clickteam #apDiv4 .clickteam .clickteam {
-
position:absolute;
+
font-size: 16px;
-
left:537px;
+
font-family: "Times New Roman", Times, serif;
-
top:493px;
+
-
width:136px;
+
-
height:29px;
+
-
z-index:4;
+
}
}
-
.clickteam #apDiv6 table {
+
.clickteam #apDiv4 table tr td p {
-
font-size: 12px;
+
font-size: 14px;
-
color: #000;
+
color: #366;
}
}
-
#apDiv7 { position:absolute;
+
.clickteam #apDiv4 table tr td {
-
left:539px;
+
font-family: Arial, Helvetica, sans-serif;
-
top:503px;
+
-
width:136px;
+
-
height:29px;
+
-
z-index:4;
+
}
}
-
#apDiv8 { position:absolute;
+
.clickteam #apDiv4 table tr td {
-
left:539px;
+
color: #366;
-
top:503px;
+
-
width:136px;
+
-
height:29px;
+
-
z-index:4;
+
}
}
-
#apDiv9 { position:absolute;
+
.aRA {
-
left:537px;
+
font-family: Arial, Helvetica, sans-serif;
-
top:493px;
+
-
width:136px;
+
-
height:29px;
+
-
z-index:4;
+
-
}
+
-
#apDiv10 { position:absolute;
+
-
left:537px;
+
-
top:493px;
+
-
width:136px;
+
-
height:29px;
+
-
z-index:4;
+
-
}
+
-
.clickteam #apDiv4 .clickteam {
+
-
font-family: Georgia, "Times New Roman", Times, serif;
+
}
}
</style>
</style>
 +
<script src="file:///C|/Users/lenovo/AppData/Roaming/Adobe/Dreamweaver CS5/zh_CN/Configuration/Temp/Assets/eam452C.tmp/includes/ice/ice.js" type="text/javascript"></script>
</head>
</head>
<body class="clickteam">
<body class="clickteam">
<div id="apDiv1">
<div id="apDiv1">
-
   <p class="notbookmaintitle">  Investigation of Antibiotic Use and</p>
+
   <p class="notbookmaintitle">  &nbsp;  Review of Antibiotic Use and Potential Harms</p>
-
  <p class="notbookmaintitle"> Related Biosafety Issues: What's </p>
+
-
  <p class="notbookmaintitle">happening out there and further.  </p>
+
-
  <p class="notbookmaintitle">&nbsp;</p>
+
   <hr />
   <hr />
   <p class="notbookmaintitle">&nbsp;</p>
   <p class="notbookmaintitle">&nbsp;</p>
Line 258: Line 231:
</div>
</div>
<div id="apDiv4">
<div id="apDiv4">
-
   <p>In order to investigate the extent to which laboratories understand biosafety issues in regard to antibiotic use, we have carried out a  survey involving about 150 participants (including  researchers from laboratories in the College of Life sciences and College of  Chemistry and Molecular Engineering in Peking University, and employees at a  few sequencing companies) who responded to a series of questions related with treatment of antibiotic-resistant bacteria in the  laboratory. (For the majority of the participants, who are non-English  speakers, a Chinese version of the questionnaire was provided so that  difficulties in understanding survey questions were minimized.)</p>
+
   <p class="mainbody">Since their discovery, antibiotics have been considered as the primary solution to most infectious diseases and  have saved billions of lives. However, the abuse of antibiotics, combined with the widespread use of antibiotic resistance genes as selection markers, have lead to a worldwide hazard to public health - bacterial antibiotic resistance. It has become much easier to find antibiotic-resistant bacteria around us<a href="#r1">[1]</a>. Increasing reports regarding superbugs - bacteria that are resistant to most common antibiotics - is also raising public concern. They have posed great threats to public health by increasing the possibilities of infectious disease outbreaks, such as the recent <em>E</em>.<em>coli</em> outbreak in Europe a few months  ago. <em>E.U</em>. has reported 25,000 deaths  caused by bacterial infection, which has even outsmarted newly invented  antibiotics<a href="#r2">[2]</a>. (See <a href="http://blogs.nature.com/news/2011/06/europes_e_coli_outbreak_time_f.html">http://blogs.nature.com/news/2011/06/europes_e_coli_out-break_time_f.html</a> for a full version of the report)</p>
-
  <p> According to the responses given by the  number of participants who have responded, it may be concluded that, in general, laboratory researchers are aware of potential safety issues related  with the use of antibiotic and resistance genes, but the level of awareness is far from sufficient for restricting laboratory work in a way that minimizes  possible hazards as a consequence of microbes’ antibiotic resistance.</p>
+
   <table width="400" border="0" cellspacing="0" cellpadding="0" align="left">
-
  <p> The first few questions look into the extent to which antibiotics and antibiotic-resistant bacteria (ARB) are employed in laboratory research. It may be seen that over eighty percent of laboratories use ARB for  at least half of their experiments (Q2), and that approximately one fifth of  them use bacteria with multi-antibiotic resistance (Q3). Therefore, there exists a large pool of antibiotic resistance that is foreseeable threats to the  environment.<br />
+
     <tr >
-
    Question 2</p>
+
       <th scope="col" >&nbsp;</th>
-
  <p><img src="https://static.igem.org/mediawiki/2011/4/40/PwekingR_hp_Q2.png" width="500" height="282" hspace="50" /></p>
+
      <th scope="col" ice:editable="*"><img src="https://static.igem.org/mediawiki/2011/f/f5/PekingR_HZI_enterohemorrhagic_E._coli.png" width="373" height="286" hspace="15" /></th>
-
  <p><br />
+
       <th rowspan="2" scope="col" ice:editable="*">&nbsp;</th>
-
  Question 3</p>
+
-
  <p><img src="https://static.igem.org/mediawiki/2011/9/92/PekingR_hp_Q3.png" width="500" height="385" hspace="50" /><br />
+
-
  </p>
+
-
   <table border="0" cellspacing="0" cellpadding="0" width="397">
+
-
     <tr>
+
-
       <td width="359" nowrap="nowrap" bgcolor="#E9FEF0"><br />
+
-
        A.Mostly    multi-antibiotic resistant(2.56%) </td>
+
-
       <td width="38" bgcolor="#E9FEF0"><p>&nbsp;</p></td>
+
     </tr>
     </tr>
     <tr>
     <tr>
-
       <td width="359" nowrap="nowrap" bgcolor="#E9FEF0"><p align="left">B.Half    are multi-antibiotic resistant(17.95%)</p></td>
+
       <td height="52" align="center" valign="middle"><p>.</p></td>
-
       <td width="38" bgcolor="#E9FEF0"><p>&nbsp;</p></td>
+
       <td align="center">Enterohemorrhagic <em>E.coli</em>  From HZI</td>
     </tr>
     </tr>
 +
  </table>
 +
 +
  <p class="mainbody"> It  is widely believed that the abuse of antibiotics accounts for the spread of  antibiotic-resistant bacteria. However, the fact that laboratory work also  significantly contributes to this process cannot be ignored. Our Human Practice  focuses on the treatment of used or excessive antibiotic-resistant bacteria,  and discusses feasible precautions against the spread of antibiotic-resistant  microbes.<table width="200" border="0" cellspacing="0" cellpadding="0" align="right">
     <tr>
     <tr>
-
       <td width="397" colspan="2" nowrap="nowrap" bgcolor="#E9FEF0"><p align="left">C.Only    a few are multi-antibiotic resistant(46.15%)</p></td>
+
       <th height="173" scope="col">&nbsp;</th>
 +
      <th scope="col"><img src="https://static.igem.org/mediawiki/2011/f/f1/PekingR_Httptopnews.net.nz_antibiotic_pills.jpg" width="200" height="150" /></th>
 +
      <th scope="col">&nbsp;</th>
     </tr>
     </tr>
     <tr>
     <tr>
-
       <td width="359" nowrap="nowrap" bgcolor="#E9FEF0"><p align="left">D.Almost    none(33.33%)</p></td>
+
       <td>&nbsp;</td>
-
       <td width="38" bgcolor="#E9FEF0"><p>&nbsp;</p></td>
+
      <td><p>Antibiotic pills  From topnews.net.nz
 +
      </p>
 +
       <p>&nbsp;</p></td>
 +
      <td>&nbsp;</td>
     </tr>
     </tr>
   </table>
   </table>
-
   <p>The next set of questions investigates whether used or unwanted ARB is  appropriately processed in laboratories.</p>
+
   <span class="mainbody">Inappropriate use of antibiotics is a major cause of bacterial antibiotic resistance. The public  used to depend on antibiotics to treat infections regardless of whether they are of viral origins or may be treated by means other than antibiotics. To make matters worse, in many countries, the public has access to antibiotics without  prescriptions. As the public does not strictly follow instructions at all times,  bacterial antibiotic resistance is further aggravated. The challenge in  confronting antibiotic resistance lies in the possibility that even if antibiotic use is reduced, resistant clones would remain  persistent and cannot be rapidly outcompeted by their susceptible relatives<a href="#r3">[3]</a>. </p>
-
  <p>The respondents all showed adequate levels of understanding in issues concerning possible threats induced by abandoned ARB in the laboratory. Almost equal proportions of respondents pointed out one of the four major consequences, respectively(Q9). Unfortunately, statistics revealed that over one third of the respondents reported that used ARB is never or only occasionally processed in safe and professional ways, and that a considerable portion of them has no special attention paid to the issue (Q5). Besides, results for Question 6 indicated that very few (<3%) laboratory researchers have been clearly informed of how laboratory waste should be processed in their department/organization. Even if they have somehow been informed, they did not pay much attention because they believed that laboratory waste is being appropriately processed. It is interesting that though people know that something like this may have negative effect on our life, they believe that there will be someone else to be responsible for such things. To make matters worse, more than half of the laboratories directly dispose of materials that have been in direct contact with microbes, while some others care little about the matter (Q8). This further adds to the potential danger of pollution and transfer of antibiotic resistance to microbes in the environment. Thus it seems that what is more urgent is not informing researchers of potential safety hazards of ARB but how to strictly and effectively regulate laboratory procedures to prevent these hazards. Most researchers know the consequences of their behavior, but few would take the time and effort to implement the right measures, probably because public health and environment have not yet experienced crises of sufficiently alarming levels, which we strongly wish, of course, to avoid.</p>
+
  </span>
-
  <hr />
+
<p class="mainbody">    Besides treatment of  infections, antibiotics are also widely used in agriculture, where they are  added to food for animals to prevent infectious diseases and promote growth. </p>
-
  <p>&nbsp;</p>
+
   <table width="200" border="0" cellspacing="0" cellpadding="0" align="left">
-
</div>
+
-
<div id="apDiv6">
+
-
   <table width="125" height="24" border="0" cellpadding="0" cellspacing="0">
+
     <tr>
     <tr>
-
       <th width="31" bgcolor="#E9FEF0" class="clickteam" scope="col">&nbsp;</th>
+
       <th scope="col">&nbsp;</th>
-
       <th width="16" bgcolor="#CCCCCC" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation/zmq">1</a></th>
+
       <th scope="col"><img src="https://static.igem.org/mediawiki/2011/d/de/PekingR_Antibiotic_resistance4_feature_scct.net.jpg" width="308" height="200" /></th>
-
      <th width="18" bgcolor="#E9FEF0" class="clickteam"  scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation2/zmq">2</a></th>
+
       <th scope="col">&nbsp;</th>
-
      <th width="15" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation3/zmq">3</a></th>
+
-
       <th width="45" bgcolor="#E9FEF0"class="clickteam"  scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation2/zmq">Next</a></th>
+
     </tr>
     </tr>
-
  </table>
 
-
</div>
 
-
<div id="apDiv3">
 
-
  <table width="125" height="24" border="0" cellpadding="0" cellspacing="0">
 
     <tr>
     <tr>
-
       <th width="42" bgcolor="#E9FEF0" class="clickteam" scope="col">&nbsp;</th>
+
       <td>&nbsp;</td>
-
       <th width="11" bgcolor="#CCCCCC" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation/zmq">1</a></th>
+
       <td align="left"><p class="main"> Antibiotic in agriculture  From scct.net</p></td>
-
      <th width="14" bgcolor="#E9FEF0" class="clickteam"  scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation2/zmq">2</a></th>
+
       <td>&nbsp;</td>
-
       <th width="13" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation3/zmq">3</a></th>
+
-
      <th width="45" bgcolor="#E9FEF0"class="clickteam"  scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation2/zmq">Next</a></th>
+
     </tr>
     </tr>
   </table>
   </table>
 +
  <p class="mainbody">It  is relatively more difficult for the public, however, to establish the  correlation between antibiotic use on farm animals and potential hazards to  public health. Despite the lack of statistical data confirming the scale of  antibiotic use, it is reasonable to estimate that the majority of antibiotics  and related products are used in agriculture for their cheapness and safety to  livestock. Besides, it is also unlikely that farmers will carefully control the  dosage of antibiotics applied to animals. Consequentially, excessive amounts of  antibiotics selects for bacteria with stronger resistance, and the related  genes may be transferred to other microbes through horizontal gene transfer<a href="#r4">[4]</a>,  which may then pose greater challenges to biosafety.<br />
 +
  One of the primary  goals of synthetic biology is to render the design of biological systems easier  for more researchers to take part in the design process. Great efforts have  been made to develop toolkits which are easy and convenient for users without  professional backgrounds in biology<a href="#r1">[5]</a>. The extensive use of such  toolboxes has attracted researchers from other disciplines such as engineering  and computer sciences, contributing cross-disciplinary skills and techniques to  conventional biological sciences. However, the participation of researchers  lacking systematic training in biosafety inevitably increases the risk of  biohazards, including:</p>
 +
  <p class="mainbody"><br />
 +
    1. High possibility that in the near future organizations of  non-research origins will be able to   produce recombinant or mutant species in a large scale, probably  threatening the environment and public safety.<br />
 +
    2. Improper treatment of microbes and corresponding DNA  fragments in the laboratory by researchers unaware of biosafety.</p>
 +
  <p class="mainbody"> Researchers,  being too familiar with antibiotic-resistant bacteria to treat them with  caution, may also negatively affect public safety even if they have indeed  undergone professional training in biosafety. Common treatments, such as  pouring solutions or medium containing microbes into the sewer or throwing them  into garbage cans, may expose antibiotic-resistant bacteria to the environment,  increasing the risk of transferring antibiotic-resistant genes to wildtype  microbes. A more subtle form of risk is the ever wider application of  Polymerase Chain Reaction(PCR), which allows microbial DNA fragments to be  rapidly replicated and promotes formation of mutant or recombinant DNA via  error-prone replication<a href="#r6">[6]</a>.
 +
  </p>
 +
  <p class="clickteam">&nbsp;</p>
 +
  <hr />
 +
  <p class="July">reference:</p>
 +
  <p>[1]<a name="r1" id="r1"></a>1.  Livermore, D.M. Has the era of untreatable infections arrived? <em>J. Antimicrob.  Chemother</em> <strong>64 </strong>(suppl 1), i29–36 (2009). <br />
 +
    [2].<a name="r2" id="r2"></a> As <em>E. coli </em>Outbreak Recedes, New Questions Come to the Fore. <em>Science</em> <strong>333</strong>, 27 (2011).<br />
 +
    [3]. <a name="r3" id="r3"></a>Andersson, D.I., and Hughes, D., Persistence of antibiotic resistance in  bacterial populations. <em>FEMS Microbiol Rev</em>(2011).<em>­</em>(Accepted Article)<br />
 +
    [4].<a name="r4" id="r4"></a> Wiedenbeck, J., and Cohan, F.M., Origins of  Bacterial Diversity through Horizontal Genetic Transfer and Adaptation to New  Ecological Niches. <em>FEMS Microbiol Rev</em>(2011).<em>­</em>(Accepted Article) <br />
 +
    [5].<a name="r5" id="r5"></a> Schmidt, M., Diffusion of synthetic biology: a challenge to biosafety. <em>Syst Synth Biol</em> <strong>2</strong>, 1–6 (2008).<br />
 +
    [6].<a name="r6" id="r6"></a> Bügl, H., Danner, J.P., Molinari, R.J., Mulligan, J.T., Park, H., Bas  Reichert, Roth, D.A., Wagner, R., Budowle, B., Scripp, R.M., Smith, J.A.L.,  Steele, S.J., Church, G., and Endy, D., DNA Synthesis and Biological Security. <em>Nat Biotech</em> <strong>25</strong>, 627-629  (2007).</p>
 +
  <p class="clickteam">&nbsp; </p>
 +
  <p class="download">&nbsp;</p>
 +
</div>
 +
<div id="apDiv5">
 +
  <hr />
 +
  <p class="July">&nbsp;</p>
</div>
</div>
</body>
</body>
</html>
</html>

Latest revision as of 09:24, 5 October 2011

Template:Https://2011.igem.org/Team:Peking R/bannerhidden Template:Https://2011.igem.org/Team:Peking R/back2 Template:Https://2011.igem.org/Team:Peking R/Humanpracticebackground 无标题文档

  Review of Antibiotic Use and Potential Harms


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Since their discovery, antibiotics have been considered as the primary solution to most infectious diseases and have saved billions of lives. However, the abuse of antibiotics, combined with the widespread use of antibiotic resistance genes as selection markers, have lead to a worldwide hazard to public health - bacterial antibiotic resistance. It has become much easier to find antibiotic-resistant bacteria around us[1]. Increasing reports regarding superbugs - bacteria that are resistant to most common antibiotics - is also raising public concern. They have posed great threats to public health by increasing the possibilities of infectious disease outbreaks, such as the recent E.coli outbreak in Europe a few months ago. E.U. has reported 25,000 deaths caused by bacterial infection, which has even outsmarted newly invented antibiotics[2]. (See http://blogs.nature.com/news/2011/06/europes_e_coli_out-break_time_f.html for a full version of the report)

   

.

Enterohemorrhagic E.coli  From HZI

It is widely believed that the abuse of antibiotics accounts for the spread of antibiotic-resistant bacteria. However, the fact that laboratory work also significantly contributes to this process cannot be ignored. Our Human Practice focuses on the treatment of used or excessive antibiotic-resistant bacteria, and discusses feasible precautions against the spread of antibiotic-resistant microbes.

   
 

Antibiotic pills  From topnews.net.nz

 

 
Inappropriate use of antibiotics is a major cause of bacterial antibiotic resistance. The public used to depend on antibiotics to treat infections regardless of whether they are of viral origins or may be treated by means other than antibiotics. To make matters worse, in many countries, the public has access to antibiotics without prescriptions. As the public does not strictly follow instructions at all times, bacterial antibiotic resistance is further aggravated. The challenge in confronting antibiotic resistance lies in the possibility that even if antibiotic use is reduced, resistant clones would remain persistent and cannot be rapidly outcompeted by their susceptible relatives[3].

Besides treatment of infections, antibiotics are also widely used in agriculture, where they are added to food for animals to prevent infectious diseases and promote growth.

   
 

Antibiotic in agriculture  From scct.net

 

It is relatively more difficult for the public, however, to establish the correlation between antibiotic use on farm animals and potential hazards to public health. Despite the lack of statistical data confirming the scale of antibiotic use, it is reasonable to estimate that the majority of antibiotics and related products are used in agriculture for their cheapness and safety to livestock. Besides, it is also unlikely that farmers will carefully control the dosage of antibiotics applied to animals. Consequentially, excessive amounts of antibiotics selects for bacteria with stronger resistance, and the related genes may be transferred to other microbes through horizontal gene transfer[4], which may then pose greater challenges to biosafety.
One of the primary goals of synthetic biology is to render the design of biological systems easier for more researchers to take part in the design process. Great efforts have been made to develop toolkits which are easy and convenient for users without professional backgrounds in biology[5]. The extensive use of such toolboxes has attracted researchers from other disciplines such as engineering and computer sciences, contributing cross-disciplinary skills and techniques to conventional biological sciences. However, the participation of researchers lacking systematic training in biosafety inevitably increases the risk of biohazards, including:


1. High possibility that in the near future organizations of non-research origins will be able to  produce recombinant or mutant species in a large scale, probably threatening the environment and public safety.
2. Improper treatment of microbes and corresponding DNA fragments in the laboratory by researchers unaware of biosafety.

Researchers, being too familiar with antibiotic-resistant bacteria to treat them with caution, may also negatively affect public safety even if they have indeed undergone professional training in biosafety. Common treatments, such as pouring solutions or medium containing microbes into the sewer or throwing them into garbage cans, may expose antibiotic-resistant bacteria to the environment, increasing the risk of transferring antibiotic-resistant genes to wildtype microbes. A more subtle form of risk is the ever wider application of Polymerase Chain Reaction(PCR), which allows microbial DNA fragments to be rapidly replicated and promotes formation of mutant or recombinant DNA via error-prone replication[6].

 


reference:

[1]1. Livermore, D.M. Has the era of untreatable infections arrived? J. Antimicrob. Chemother 64 (suppl 1), i29–36 (2009).
[2]. As E. coli Outbreak Recedes, New Questions Come to the Fore. Science 333, 27 (2011).
[3]. Andersson, D.I., and Hughes, D., Persistence of antibiotic resistance in bacterial populations. FEMS Microbiol Rev(2011).­(Accepted Article)
[4]. Wiedenbeck, J., and Cohan, F.M., Origins of Bacterial Diversity through Horizontal Genetic Transfer and Adaptation to New Ecological Niches. FEMS Microbiol Rev(2011).­(Accepted Article)
[5]. Schmidt, M., Diffusion of synthetic biology: a challenge to biosafety. Syst Synth Biol 2, 1–6 (2008).
[6]. Bügl, H., Danner, J.P., Molinari, R.J., Mulligan, J.T., Park, H., Bas Reichert, Roth, D.A., Wagner, R., Budowle, B., Scripp, R.M., Smith, J.A.L., Steele, S.J., Church, G., and Endy, D., DNA Synthesis and Biological Security. Nat Biotech 25, 627-629 (2007).